Keishibukuryogan is not carcinogenic in Sprague-Dawley rats

Keishibukuryogan is a traditional Japanese medicine widely administered to patients with menopausal symptoms. Because humans use it on a long-term basis, we believed that a carcinogenicity study was warranted. We orally administered keishibukuryogan (TJ-25) extract powder to 6-week-old Sprague-Dawle...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanitani, Masanao, Nishimura, Nobuo, Edamoto, Hiroshi, Kase, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Toxicologic Pathology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866007/
https://www.ncbi.nlm.nih.gov/pubmed/27182114
http://dx.doi.org/10.1293/tox.2015-0017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866007/
https://www.ncbi.nlm.nih.gov/pubmed/27182114
http://dx.doi.org/10.1293/tox.2015-0017

Ejemplares similares